Cetrelimab 480 mg clinical trials

A Study of Niraparib Combination Therapies for the Treatment of Metastatic Castration-Resistant Prostate Cancer

This study looks at new drug combinations to treat prostate cancer that has spread and is no longer responding to standard hormone therapy. Researchers want to see how safe and effective these new combinations are and how the body handles them.